Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
RNS Number:4707U HG Capital Trust PLC 21 January 2004 The following is the text of a press release issued by HgCapital, manager of the investment portfolio of HgCapital Trust plc...
RNS Number:1794U Alizyme PLC 13 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...
RNS Number:0774U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME FILES NEW PATENT APPLICATION FOR RENZAPRIDE Cambridge UK, 12 January 2004:...
RNS Number:0770U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME SUCCESSFULLY COMPLETES CLINICAL TRIAL FOR RENZAPRIDE IN IRRITABLE BOWEL SYNDROME PATIENTS IN...
RNS Number:6633T Alizyme PLC 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...
RNS Number:4599T Alizyme PLC 19 December 2003 For Immediate Release 19 December 2003 ALIZYME GRANTED CTX FOR PHASE IIa CLINICAL TRIAL FOR ATL-104 FOR MUCOSITIS Cambridge UK, 19...
RNS Number:8723R Alizyme PLC 10 November 2003 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Alizyme plc 2. Name of scheme Alizyme plc Share Option Scheme...
RNS Number:3073R Alizyme PLC 24 October 2003 For Immediate Release 24 October 2003 ALIZYME PLC DIRECTOR SHARE PURCHASE Alizyme plc (the "Company") received notification...
RNS Number:1606R Alizyme PLC 22 October 2003 Immediate Release 22 October 2003 ALIZYME PLC Institutional Placing Raises #11.5 million Alizyme Plc ("Alizyme" or "the...
RNS Number:7020Q Alizyme PLC 09 October 2003 Immediate Release 9 October 2003 ALIZYME ANNOUNCES GRANT OF USA PATENT FOR ATL-962 FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.08 | -0.348583877996 | 22.95 | 23.57 | 22.52 | 823433 | 23.1018833 | DE |
| 4 | -0.91 | -3.826745164 | 23.78 | 23.91 | 22.33 | 758806 | 23.01102152 | DE |
| 12 | 0.51 | 2.28085867621 | 22.36 | 24.49 | 21.55 | 589876 | 22.94178374 | DE |
| 26 | -2.16 | -8.62964442669 | 25.03 | 25.12 | 20.16 | 539741 | 22.91865322 | DE |
| 52 | 0.6 | 2.69420745397 | 22.27 | 27.44 | 20.16 | 626153 | 23.9971942 | DE |
| 156 | -3.43 | -13.0418250951 | 26.3 | 27.44 | 13.81 | 643711 | 21.5631148 | DE |
| 260 | 0.01 | 0.0437445319335 | 22.86 | 27.44 | 10.265 | 920782 | 19.74664305 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
